A Case of Severe Hypercalcemia in a Patient Taking Tirzepatide: Potential Risk Factors.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
tirzepatide
hypercalcemia
case-report
chronic-kidney-disease
drug-interaction
glp-1-agonist
